MeiraGTx Holdings (MGTX) Free Cash Flow (QoQ) (2017 - 2025)
MeiraGTx Holdings (MGTX) Free Cash Flow (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - |
| 3 | BeOne Medicines | 473.13 Bn | 468.34 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.67 Bn | 116.43 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.57 Bn | 62.81 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - |
| 7 | Argenx Se | 54.61 Bn | 49.42 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 37.99 Bn | 34.98 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.09 Bn | 36.09 Bn | - |
| 10 | MeiraGTx Holdings | 953.10 Mn | 887.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 461.47% |
| Sep 30, 2025 | 71.63% |
| Jun 30, 2025 | -17.40% |
| Mar 31, 2025 | -57.22% |
| Dec 31, 2024 | 4.89% |
| Sep 30, 2024 | -11.50% |
| Jun 30, 2024 | 36.04% |
| Mar 31, 2024 | -120.97% |
| Dec 31, 2023 | -50.62% |
| Sep 30, 2023 | 68.08% |
| Jun 30, 2023 | 26.11% |
| Mar 31, 2023 | 24.74% |
| Dec 31, 2022 | -1,186.95% |
| Sep 30, 2022 | 113.45% |
| Jun 30, 2022 | -101.40% |
| Mar 31, 2022 | -274.63% |
| Dec 31, 2021 | 80.95% |
| Sep 30, 2021 | -8.39% |
| Jun 30, 2021 | -685.43% |
| Mar 31, 2021 | 112.20% |